Chronic myeloid leukemia manifested during megakaryoblastic crisis

Southern Medical Journal

Volumn 89, Issue 4, 1996, Pages 422-427

  Wu, C Daniel ^a   Medeiros, L Jeffrey ^a,b   Miranda, Roberto N ^a   Mark, Hon Fong L ^a   Rintels, Peter ^a  

^a BROWN UNIVERSITY   (United States)

^b CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTARABINE; ETOPOSIDE;

ADULT; ARTICLE; BLAST CELL CRISIS; CANCER COMBINATION CHEMOTHERAPY; CANCER REGRESSION; CASE REPORT; CHRONIC MYELOID LEUKEMIA; CLINICAL FEATURE; CYTOGENETICS; HUMAN; LEUKOCYTE DIFFERENTIAL COUNT; MALE; MEGAKARYOCYTE; THROMBOCYTE COUNT;

ADULT; ANTIMETABOLITES, ANTINEOPLASTIC; BLAST CRISIS; BONE MARROW; BONE MARROW TRANSPLANTATION; CYTARABINE; FATAL OUTCOME; HUMANS; LEUKEMIA, MEGAKARYOCYTIC, ACUTE; LEUKEMIA, MYELOID, CHRONIC; MALE;

EID: 0029964491     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007611-199604000-00016     Document Type: Article

References (30)

1. Ross DW, Brunning RD, Karterjian HM, et al: A proposed staging system for chronic myeloid leukemia. Cancer 1993; 71:3788-3791
2. Peterson LC, BLoomfield CD, Brunning RD: Blast crisis as an initial or terminal manifestation of chronic myeloid leukemia. Am J Med 1976; 60:209-220
3. Hehlmann R, Heimpel H, Hasford J, et al: Randomized comparison of busulfan and hydroxyurea in chronic myelogenous leukemia: prolongation of survival by hydroxyurea. Blood 1993; 82:398-407
4. Hernandez JM, Gonzalez-Sarmiento R, Martin C, et al: Immunophenotypic, genomic and clinical characteristics of blast crisis of chronic myelogenous leukaemia. Br J Haematol 1991; 79:408-414
5. Bearman RM, Pangalis GA, Rappaport H: Acute ("malignant") myelofibrosis. Cancer 1979; 43:279-293
6. Truong LD, Saleem A, Schwartz MR: Acute myelofibrosis: a report of four cases and review of the literature. Medicine 1984; 63:182-187
7. Den Ottolander GJ, Te Velde J, Brederoo P, et al: Megakaryoblastic leukaemia (acute myelofibrosis): a report of three cases. Br J Haematol 1979; 42:9-20
8. Huang M-J, Li C-Y, Nichols WL, et al: Acute leukemia with megakaryocytic differentiation: a study of 12 cases identified immunocytochemically. Blood 1984; 64:427-439
9. Cuneo A, Mecucci C, Kerim S, et al: Multipotent stem cell involvement in megakaryoblastic leukemia: cytologic and cytogenetic evidence in 15 patients. Blood 1989; 74:1781-1790
10. Hafliger B, Gratwohl A, Tichelli A, et al: High dose ara-C and VP-16 before conditioning for bone marrow transplantation in patients with high-risk leukemia. Semin Oncol 1987; 14 (suppl 1):134-138
11. Innes DJ, Mills SE, Walker GK: Megakaryocytic leukemia. identification utilizing anti-factor VIII immunoperoxidase. Am J Clin Pathol 1982; 77:107-110
12. 1-positive megakaryoblastic leukemia. Cancer 1975; 36:576-581
13. Bain B, Catovsky D, O'Brien M, et al: Megakaryoblastic transformation of chronic granulocytic leukaemia, an electron microscopy and cytochemical study. J Clin Pathol 1977; 30:235-242
14. Udomratn T, Steinberg MH, Dreiling BJ, et al: Circulating micromegakaryocytes signaling blast transformation of chronic myeloid leukemia. Scand J Haematol 1976; 16 394-400
15. Amin MB, Maeda K, Carey JL, et al: Megakaryoblastic termination of myeloproliferative disorders. Henry Ford Hosp Med J 1992; 40:122-126
16. San-Miguel SF, Gonzalez M, Canizo MC, et al: Leukemias with megakaryoblastic involvement: clinical, hematologic, and immunologic characteristics. Blood 1988; 72:402-407
17. Ohyashiki K, Ohyashiki JH, Hojo H, et al: Cytogenetic findings in adult acute leukemia and myeloproliferative disorders with an involvement of megakaryocyte lineage. Cancer 1990; 65:940-948
18. Kantarjian H, Keating MJ, Talpaz M, et al: Chronic myelogenous leukemia in blast crisis: analysis of 242 patients. Am J Med 1987; 83:445-454
19. Muehleck SD, McKenna RW, Arthur DC, et al: Transformation of chronic myelogenous leukemia: clinical, morphologic and cytogenetic features. Am J Clin Pathol 1984; 82:1-14
20. Lestingi TM, Hooberman AI: Philadelphia chromosome-positive acute lymphoblastic leukemia. Hematol Oncol Clin North Am 1993; 7:161-175
21. 1-positive acute leukaemia and chronic granulocytic leukaemia: one or two diseases? Br J Haematol 1979; 42:493-498
22. Kurzrock R, Shtalrid M, Talpaz M, et al: Expression of (-abl in Philadelphia positive acute myelogenous leukemia. Blood 1987; 70:1584-1588
23. Helenglass G, Testa JR, Schiffer CA: Philadelphia chromosome-positive acute leukemia: morphologic and clinical correlations. Am J Hematol 1987; 25:311-324
24. Ruiz-Arguelles GJ, Marin-Lopez A, Lobato-Mendizabal E et al: Acute megakaryoblastic leukemia, a prospective study of its identification and treatment. Br J Haematol 1986; 62:55-63
25. Ruiz-Arguelles GJ, Lobato-Mendizabal E, San-Miguel JF, et al: Long-term treatment results for acute megakaryoblastic leukaemia patients: a multicentre study. Br J Haematol 1992; 82:671-675
26. Lu G, Altman AJ, Benn PA: Review of the cytogenetic changes in acute megakaryoblastic leukemia: one disease or several? Cancer Genet Cytogenet 1993; 67:81-89
27. de Oliveira JS, Sale GE, Brjant EM, et al: Acute megakaryoblastic leukemia in children: treatment with bone marrow transplantation. Bone Marrow Transplant 1992; 10:399-403
28. Koike T, Urushiyama M, Narita M, et al: Target cell of leukemic transformation in acute megakaryocytic leukemia. Am J Hematol 1990; 34:252-258
29. Najfeld V, Zucker-Franklin D, Adamson J, et al: Evidence for clonal development and stem cell origin of M7 megakaryocytic leukemia. Leukemia 1988; 2:351-357
30. Wolf JL, Spruce WE, Bearman RM, et al: Reversal of acute (malignant) myclofibrosis by allogeneic bone marrow transplantation. Blood 1982; 59:191-193